<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26378567</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Honokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits Dengue Virus Type 2 Infection.</ArticleTitle><Pagination><StartPage>4894</StartPage><EndPage>4910</EndPage><MedlinePgn>4894-910</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/v7092852</ELocationID><Abstract><AbstractText>Dengue is the most widespread arbovirus infection and poses a serious health and economic issue in tropical and subtropical countries. Currently no licensed vaccine or compounds can be used to prevent or manage the severity of dengue virus (DENV) infection. Honokiol, a lignan biphenol derived from the Magnolia tree, is commonly used in Eastern medicine. Here we report that honokiol has profound antiviral activity against serotype 2 DENV (DENV-2). In addition to inhibiting the intracellular DENV-2 replicon, honokiol was shown to suppress the replication of DENV-2 in baby hamster kidney (BHK) and human hepatocarcinoma Huh7 cells. At the maximum non-toxic dose of honokiol treatment, the production of infectious DENV particles was reduced &gt;90% in BHK and Huh7 cells. The underlying mechanisms revealed that the expression of DENV-2 nonstructural protein NS1/NS3 and its replicating intermediate, double-strand RNA, was dramatically reduced by honokiol treatment. Honokiol has no effect on the expression of DENV putative receptors, but may interfere with the endocytosis of DENV-2 by abrogating the co-localization of DENV envelope glycoprotein and the early endosomes. These results indicate that honokiol inhibits the replication, viral gene expression, and endocytotic process of DENV-2, making it a promising agent for chemotherapy of DENV infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Chih-Yeu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan. phildts@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Siang-Jyun</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien 974,Taiwan. 610013122@ems.ndhu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Huey-Nan</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology, Academia Sinica, Taipei 11529, Taiwan. hnwu@gate.sinica.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ping</LastName><ForeName>Yueh-Hsin</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University,Taipei 112, Taiwan. yhping@ym.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biophotonics, National Yang-Ming University, Taipei 112, Taiwan. yhping@ym.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ching-Yen</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien 974,Taiwan. jouyuan22@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiuan</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien 974,Taiwan. shiuan@mail.ndhu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chi-Long</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 116, Taiwan. chencl@tmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Taipei Medical University Hospital, Taipei Medical University,Taipei 110, Taiwan. chencl@tmu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ying-Ray</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Department of Medical Research, Chiayi Christian Hospital, Chiayi 600, Taiwan. yingray.lee@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nursing, Min-Hwei College of Health Care Management, Tainan 73658, Taiwan. yingray.lee@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Kao-Jean</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien 974,Taiwan. kj-huang@dcb.org.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biologics, Development Center for Biotechnology, New Taipei City 22180, Taiwan. kj-huang@dcb.org.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001713">Biphenyl Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017705">Lignans</NameOfSubstance></Chemical><Chemical><RegistryNumber>11513CCO0N</RegistryNumber><NameOfSubstance UI="C005499">honokiol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001713" MajorTopicYN="N">Biphenyl Compounds</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015967" MajorTopicYN="N">Gene Expression Regulation, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017705" MajorTopicYN="N">Lignans</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D031566" MajorTopicYN="N">Magnolia</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Magnolia</Keyword><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">honokiol</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26378567</ArticleId><ArticleId IdType="pmc">PMC4584296</ArticleId><ArticleId IdType="doi">10.3390/v7092852</ArticleId><ArticleId IdType="pii">v7092852</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Normile D. Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts. Science. 2013;342 doi: 10.1126/science.342.6157.415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.342.6157.415</ArticleId><ArticleId IdType="pubmed">24159024</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S.B. Pathogenesis of dengue: Challenges to molecular biology. Science. 1988;239:476&#x2013;481. doi: 10.1126/science.3277268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3277268</ArticleId><ArticleId IdType="pubmed">3277268</ArticleId></ArticleIdList></Reference><Reference><Citation>Henchal E.A., Putnak J.R. The dengue viruses. Clin. Microbiol. Rev. 1990;3:376&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC358169</ArticleId><ArticleId IdType="pubmed">2224837</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler D.J. The economic burden of dengue. Am. J. Trop. Med. Hyg. 2012;86:743&#x2013;744. doi: 10.4269/ajtmh.2012.12-0157.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2012.12-0157</ArticleId><ArticleId IdType="pmc">PMC3335674</ArticleId><ArticleId IdType="pubmed">22556068</ArticleId></ArticleIdList></Reference><Reference><Citation>Beecher G.R. Overview of dietary flavonoids: Nomenclature, occurrence and intake. J. Nutr. 2003;133:3248S&#x2013;3254S.</Citation><ArticleIdList><ArticleId IdType="pubmed">14519822</ArticleId></ArticleIdList></Reference><Reference><Citation>Clifford M.N. Diet-derived phenols in plasma and tissues and their implications for health. Planta Med. 2004;70:1103&#x2013;1114. doi: 10.1055/s-2004-835835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2004-835835</ArticleId><ArticleId IdType="pubmed">15643541</ArticleId></ArticleIdList></Reference><Reference><Citation>Naithani R., Huma L.C., Holland L.E., Shukla D., McCormick D.L., Mehta R.G., Moriarty R.M. Antiviral activity of phytochemicals: A comprehensive review. Mini Rev. Med. Chem. 2008;8:1106&#x2013;1133. doi: 10.2174/138955708785909943.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138955708785909943</ArticleId><ArticleId IdType="pubmed">18855727</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman M. Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol. Nutr. Food Res. 2007;51:116&#x2013;134. doi: 10.1002/mnfr.200600173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200600173</ArticleId><ArticleId IdType="pmc">PMC7168386</ArticleId><ArticleId IdType="pubmed">17195249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.J., Lee Y.M., Lee C.K., Jung J.K., Han S.B., Hong J.T. Therapeutic applications of compounds in the Magnolia family. Pharmacol. Ther. 2011;130:157&#x2013;176. doi: 10.1016/j.pharmthera.2011.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2011.01.010</ArticleId><ArticleId IdType="pubmed">21277893</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried L.E., Arbiser J.L. Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid. Redox Signal. 2009;11:1139&#x2013;1148. doi: 10.1089/ars.2009.2440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2440</ArticleId><ArticleId IdType="pmc">PMC2842137</ArticleId><ArticleId IdType="pubmed">19203212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Liu X., Zhu Y., Chen S., Zhou D., Wang Y. Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-&#x3ba;B activation and cytokine production of glial cells. Neurosci. Lett. 2013;534:123&#x2013;127. doi: 10.1016/j.neulet.2012.11.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2012.11.052</ArticleId><ArticleId IdType="pubmed">23262090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H., Zhang X.X., Wang Y.Y., Chen S.Z. Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. Acta Pharmacol. Sin. 2005;26:1063&#x2013;1068. doi: 10.1111/j.1745-7254.2005.00164.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-7254.2005.00164.x</ArticleId><ArticleId IdType="pubmed">16115372</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou K.T., Shen Y.C., Chen C.F., Tsao C.M., Tsai S.K. Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res. 2003;992:159&#x2013;166. doi: 10.1016/j.brainres.2003.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2003.08.026</ArticleId><ArticleId IdType="pubmed">14625055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.R., Chen H.H., Ko C.H., Chan M.H. Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur. J. Pharmacol. 2006;537:64&#x2013;69. doi: 10.1016/j.ejphar.2006.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2006.03.035</ArticleId><ArticleId IdType="pubmed">16631734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Duan X., Yang G., Zhang X., Deng L., Zheng H., Deng C., Wen J., Wang N., Peng C., et al. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS ONE. 2011;6:e18490. doi: 10.1371/journal.pone.0018490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0018490</ArticleId><ArticleId IdType="pmc">PMC3084695</ArticleId><ArticleId IdType="pubmed">21559510</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan K.H., Wang Y.W., Lee W.P., Lan K.L., Tseng S.H., Hung L.R., Yen S.H., Lin H.C., Lee S.D. Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver Int. 2012;32:989&#x2013;997. doi: 10.1111/j.1478-3231.2011.02621.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1478-3231.2011.02621.x</ArticleId><ArticleId IdType="pubmed">22098176</ArticleId></ArticleIdList></Reference><Reference><Citation>Thisyakorn U., Thisyakorn C. Latest developments and future directions in dengue vaccines. Ther. Adv. Vaccines. 2014;2:3&#x2013;9. doi: 10.1177/2051013613507862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2051013613507862</ArticleId><ArticleId IdType="pmc">PMC3991153</ArticleId><ArticleId IdType="pubmed">24757522</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Kouri G. Dengue: An update. Lancet Infect. Dis. 2002;2:33&#x2013;42. doi: 10.1016/S1473-3099(01)00171-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(01)00171-2</ArticleId><ArticleId IdType="pubmed">11892494</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavige G.N., Fernando S., Fernando D.J., Seneviratne S.L. Dengue viral infections. Postgrad. Med. J. 2004;80:588&#x2013;601. doi: 10.1136/pgmj.2004.019638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2004.019638</ArticleId><ArticleId IdType="pmc">PMC1743110</ArticleId><ArticleId IdType="pubmed">15466994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouri G.P., Guzman M.G., Bravo J.R., Triana C. Dengue haemorrhagic fever/dengue shock syndrome: Lessons from the Cuban epidemic, 1981. Bull. World Health Organ. 1989;67:375&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2491263</ArticleId><ArticleId IdType="pubmed">2805215</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y.C., Chen N.C., Chen P.C., Wang C.C., Cheng W.C., Wu H.N. Identification of a small-molecule inhibitor of dengue virus using a replicon system. Arch. Virol. 2012;157:681&#x2013;688. doi: 10.1007/s00705-012-1224-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-012-1224-z</ArticleId><ArticleId IdType="pubmed">22249364</ArticleId></ArticleIdList></Reference><Reference><Citation>Grove J., Marsh M. The cell biology of receptor-mediated virus entry. J. Cell Biol. 2011;195:1071&#x2013;1082. doi: 10.1083/jcb.201108131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201108131</ArticleId><ArticleId IdType="pmc">PMC3246895</ArticleId><ArticleId IdType="pubmed">22123832</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera-Lecoin M., Meertens L., Carnec X., Amara A. Flavivirus entry receptors: An update. Viruses. 2014;6:69&#x2013;88. doi: 10.3390/v6010069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6010069</ArticleId><ArticleId IdType="pmc">PMC3917432</ArticleId><ArticleId IdType="pubmed">24381034</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Schaar H.M., Rust M.J., Chen C., van der Ende-Metselaar H., Wilschut J., Zhuang X., Smit J.M. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 2008;4:e1000244. doi: 10.1371/journal.ppat.1000244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000244</ArticleId><ArticleId IdType="pmc">PMC2592694</ArticleId><ArticleId IdType="pubmed">19096510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaitseva E., Yang S.T., Melikov K., Pourmal S., Chernomordik L.V. Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathog. 2010;6:e1001131. doi: 10.1371/journal.ppat.1001131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001131</ArticleId><ArticleId IdType="pmc">PMC2951369</ArticleId><ArticleId IdType="pubmed">20949067</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit J.M., Moesker B., Rodenhuis-Zybert I., Wilschut J. Flavivirus cell entry and membrane fusion. Viruses. 2011;3:160&#x2013;171. doi: 10.3390/v3020160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3020160</ArticleId><ArticleId IdType="pmc">PMC3206597</ArticleId><ArticleId IdType="pubmed">22049308</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahm E.R., Singh S.V. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol. Cancer Ther. 2007;6:2686&#x2013;2695. doi: 10.1158/1535-7163.MCT-07-0217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-07-0217</ArticleId><ArticleId IdType="pubmed">17938262</ArticleId></ArticleIdList></Reference><Reference><Citation>Phoolcharoen W., Smith D.R. Internalization of the dengue virus is cell cycle modulated in HepG2, but not Vero cells. J. Med. Virol. 2004;74:434&#x2013;441. doi: 10.1002/jmv.20195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20195</ArticleId><ArticleId IdType="pubmed">15368519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T., Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 2009;21:317&#x2013;337. doi: 10.1093/intimm/dxp017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxp017</ArticleId><ArticleId IdType="pmc">PMC2721684</ArticleId><ArticleId IdType="pubmed">19246554</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenardo M.J., Fan C.M., Maniatis T., Baltimore D. The involvement of NF-&#x3ba;B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell. 1989;57:287&#x2013;294. doi: 10.1016/0092-8674(89)90966-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90966-5</ArticleId><ArticleId IdType="pubmed">2495183</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang T.H., Chen S.R., Yu C.Y., Lin Y.S., Chen Y.S., Kubota T., Matsuoka M., Lin Y.L. Dengue virus serotype 2 blocks extracellular signal-regulated kinase and nuclear factor-&#x3ba;B activation to downregulate cytokine production. PLoS ONE. 2012;7:e41635. doi: 10.1371/journal.pone.0041635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0041635</ArticleId><ArticleId IdType="pmc">PMC3425550</ArticleId><ArticleId IdType="pubmed">22927911</ArticleId></ArticleIdList></Reference><Reference><Citation>Wati S., Li P., Burrell C.J., Carr J.M. Dengue virus (DV) replication in monocyte-derived macrophages is not affected by tumor necrosis factor alpha (TNF-&#x3b1;), and DV infection induces altered responsiveness to TNF-alpha stimulation. J. Virol. 2007;81:10161&#x2013;10171. doi: 10.1128/JVI.00313-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00313-07</ArticleId><ArticleId IdType="pmc">PMC2045434</ArticleId><ArticleId IdType="pubmed">17626094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn K.S., Sethi G., Shishodia S., Sung B., Arbiser J.L., Aggarwal B.B. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol. Cancer Res. 2006;4:621&#x2013;633. doi: 10.1158/1541-7786.MCR-06-0076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-06-0076</ArticleId><ArticleId IdType="pubmed">16966432</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse A.K., Wan C.K., Shen X.L., Yang M., Fong W.F. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-&#x3ba;B-regulated gene expression through suppression of IKK activation. Biochem. Pharmacol. 2005;70:1443&#x2013;1457. doi: 10.1016/j.bcp.2005.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2005.08.011</ArticleId><ArticleId IdType="pubmed">16181613</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon A., Tough D.F. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 2002;14:432&#x2013;436. doi: 10.1016/S0952-7915(02)00354-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-7915(02)00354-0</ArticleId><ArticleId IdType="pubmed">12088676</ArticleId></ArticleIdList></Reference><Reference><Citation>Stetson D.B., Medzhitov R. Type I interferons in host defense. Immunity. 2006;25:373&#x2013;381. doi: 10.1016/j.immuni.2006.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.08.007</ArticleId><ArticleId IdType="pubmed">16979569</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan J.L. Subversion of interferon by dengue virus. Curr. Top. Microbiol. Immunol. 2010;338:35&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">19802576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashour J., Laurent-Rolle M., Shi P.Y., Garcia-Sastre A. NS5 of dengue virus mediates STAT2 binding and degradation. J. Virol. 2009;83:5408&#x2013;5418. doi: 10.1128/JVI.02188-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02188-08</ArticleId><ArticleId IdType="pmc">PMC2681973</ArticleId><ArticleId IdType="pubmed">19279106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzon M., Jones M., Davidson A., Chain B., Jacobs M. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J. Infect. Dis. 2009;200:1261&#x2013;1270. doi: 10.1086/605847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605847</ArticleId><ArticleId IdType="pubmed">19754307</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan J.L., Laurent-Rolle M., Ashour J., Martinez-Sobrido L., Ashok M., Lipkin W.I., Garcia-Sastre A. Inhibition of &#x3b1;/&#x3b2; interferon signaling by the NS4B protein of flaviviruses. J. Virol. 2005;79:8004&#x2013;8013. doi: 10.1128/JVI.79.13.8004-8013.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.13.8004-8013.2005</ArticleId><ArticleId IdType="pmc">PMC1143737</ArticleId><ArticleId IdType="pubmed">15956546</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J., Aguirre S., Fernandez-Sesma A. Innate immunity evasion by Dengue virus. Viruses. 2012;4:397&#x2013;413. doi: 10.3390/v4030397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4030397</ArticleId><ArticleId IdType="pmc">PMC3347034</ArticleId><ArticleId IdType="pubmed">22590678</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Chen Z., Kato N., Gale M., Jr., Lemon S.M. Distinct poly(I&#x2013;C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J. Biol. Chem. 2005;280:16739&#x2013;16747. doi: 10.1074/jbc.M414139200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M414139200</ArticleId><ArticleId IdType="pubmed">15737993</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002;10:100&#x2013;103. doi: 10.1016/S0966-842X(01)02288-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0966-842X(01)02288-0</ArticleId><ArticleId IdType="pubmed">11827812</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., Hunsperger E., Kroeger A., Margolis H.S., Martinez E., et al. Dengue: A continuing global threat. Nat. Rev. Microbiol. 2010;8:S7&#x2013;S16. doi: 10.1038/nrmicro2460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2460</ArticleId><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin A.P., Whitehead S.S. Next-generation dengue vaccines: Novel strategies currently under development. Viruses. 2011;3:1800&#x2013;1814. doi: 10.3390/v3101800.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3101800</ArticleId><ArticleId IdType="pmc">PMC3205382</ArticleId><ArticleId IdType="pubmed">22069516</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Wang T., Wu Y.F., Gu Y., Xu X.L., Zheng S., Hu X. Honokiol: A potent chemotherapy candidate for human colorectal carcinoma. World J. Gastroenterol. 2004;10:3459&#x2013;3463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4576227</ArticleId><ArticleId IdType="pubmed">15526365</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W.J., Huang X., Qin E., Jiang L., Ren P. Pharmacokinetics of honokiol in rat after oral administration of Cortex of Magnolia officinalis and its compound preparation Houpu Sanwu Decoction. Zhong Yao Cai. 2008;31:255&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">18619273</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A. Encephalitis in the clinical spectrum of dengue infection. Neurol. India. 2010;58:585&#x2013;591. doi: 10.4103/0028-3886.68655.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0028-3886.68655</ArticleId><ArticleId IdType="pubmed">20739797</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Dung N.M., Vaughn D.W., Kneen R., Thao L.T., Raengsakulrach B., Loan H.T., Day N.P., Farrar J., Myint K.S., et al. Neurological manifestations of dengue infection. Lancet. 2000;355:1053&#x2013;1059. doi: 10.1016/S0140-6736(00)02036-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)02036-5</ArticleId><ArticleId IdType="pubmed">10744091</ArticleId></ArticleIdList></Reference><Reference><Citation>Battle T.E., Arbiser J., Frank D.A. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood. 2005;106:690&#x2013;697. doi: 10.1182/blood-2004-11-4273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-11-4273</ArticleId><ArticleId IdType="pubmed">15802533</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M., Kuete V., Kadioglu O., Bortzler J., Khalid H., Greten H.J., Efferth T. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Phytomedicine. 2014;21:1525&#x2013;1533. doi: 10.1016/j.phymed.2014.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2014.07.011</ArticleId><ArticleId IdType="pubmed">25442261</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 2000;181:2&#x2013;9. doi: 10.1086/315215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315215</ArticleId><ArticleId IdType="pubmed">10608744</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayak V., Dessau M., Kucera K., Anthony K., Ledizet M., Modis Y. Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J. Virol. 2009;83:4338&#x2013;4344. doi: 10.1128/JVI.02574-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02574-08</ArticleId><ArticleId IdType="pmc">PMC2668458</ArticleId><ArticleId IdType="pubmed">19244332</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison S.C. Viral membrane fusion. Nat. Struct. Mol. Biol. 2008;15:690&#x2013;698. doi: 10.1038/nsmb.1456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1456</ArticleId><ArticleId IdType="pmc">PMC2517140</ArticleId><ArticleId IdType="pubmed">18596815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L.W., Huang Y.L., Lee J.H., Huang L.Y., Chen W.J., Lin Y.H., Chen J.Y., Xiang R., Lee C.H., Ping Y.H. Single-virus tracking approach to reveal the interaction of Dengue virus with autophagy during the early stage of infection. J. Biomed. Opt. 2014;19:011018. doi: 10.1117/1.JBO.19.1.011018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/1.JBO.19.1.011018</ArticleId><ArticleId IdType="pubmed">24192777</ArticleId></ArticleIdList></Reference><Reference><Citation>Green A.M., Beatty P.R., Hadjilaou A., Harris E. Innate immunity to dengue virus infection and subversion of antiviral responses. J. Mol. Biol. 2014;426:1148&#x2013;1160. doi: 10.1016/j.jmb.2013.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.11.023</ArticleId><ArticleId IdType="pmc">PMC4174300</ArticleId><ArticleId IdType="pubmed">24316047</ArticleId></ArticleIdList></Reference><Reference><Citation>Fensterl V., Sen G.C. Interferons and viral infections. Biofactors. 2009;35:14&#x2013;20. doi: 10.1002/biof.6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.6</ArticleId><ArticleId IdType="pubmed">19319841</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan J.L., Sanchez-Burgos G.G., Laurent-Rolle M., Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. USA. 2003;100:14333&#x2013;14338. doi: 10.1073/pnas.2335168100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2335168100</ArticleId><ArticleId IdType="pmc">PMC283592</ArticleId><ArticleId IdType="pubmed">14612562</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K.J., Li S.Y., Chen S.C., Liu H.S., Lin Y.S., Yeh T.M., Liu C.C., Lei H.Y. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. J. Gen. Virol. 2000;81:2177&#x2013;2182. doi: 10.1099/0022-1317-81-9-2177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-81-9-2177</ArticleId><ArticleId IdType="pubmed">10950974</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K.J., Yang Y.C., Lin Y.S., Huang J.H., Liu H.S., Yeh T.M., Chen S.H., Liu C.C., Lei H.Y. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J. Immunol. 2006;176:2825&#x2013;2832. doi: 10.4049/jimmunol.176.5.2825.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.5.2825</ArticleId><ArticleId IdType="pubmed">16493039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopman A.H.N., Ramaekers F.C.S., Speel E.J.M. Rapid synthesis of biotin-, digoxigenin-, trinitrophenyl-, and fluorochrome-labeled tyramides and their application for in situ hybridization using CARD amplification. J. Histochem. Cytochem. 1998;46:771&#x2013;777. doi: 10.1177/002215549804600611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/002215549804600611</ArticleId><ArticleId IdType="pubmed">9603790</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C.H., Lai L.C., Cheng H.C., Chen K.R., Syue Y.Z., Lu H.C., Lin W.Y., Chen S.H., Huang H.S., Shiau A.L., et al. TBK1-associated protein in endolysosomes (TAPE) is an innate immune regulator modulating the TLR3 and TLR4 signaling pathways. J. Biol. Chem. 2011;286:7043&#x2013;7051. doi: 10.1074/jbc.M110.164632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.164632</ArticleId><ArticleId IdType="pmc">PMC3044961</ArticleId><ArticleId IdType="pubmed">21189260</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>